Vibol Tan

Array ( [id] => 4349001 [patent_doc_number] => 06291207 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Herpes virus entry receptor protein' [patent_app_type] => 1 [patent_app_number] => 8/509024 [patent_app_country] => US [patent_app_date] => 1995-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11972 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291207.pdf [firstpage_image] =>[orig_patent_app_number] => 509024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4043376 [patent_doc_number] => 05912116 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Methods of measuring analytes with barrier webs' [patent_app_type] => 1 [patent_app_number] => 8/486651 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 42618 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912116.pdf [firstpage_image] =>[orig_patent_app_number] => 486651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834699 [patent_doc_number] => 05846734 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Mammalian adipogenic factors' [patent_app_type] => 1 [patent_app_number] => 8/485795 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 14675 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846734.pdf [firstpage_image] =>[orig_patent_app_number] => 485795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3753885 [patent_doc_number] => 05843450 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Hepatitis GB Virus synthetic peptides and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/473475 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17775 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843450.pdf [firstpage_image] =>[orig_patent_app_number] => 473475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296696 [patent_doc_number] => 06251397 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same' [patent_app_type] => 1 [patent_app_number] => 8/478316 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 24 [patent_no_of_words] => 36002 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251397.pdf [firstpage_image] =>[orig_patent_app_number] => 478316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4361704 [patent_doc_number] => 06274149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence' [patent_app_type] => 1 [patent_app_number] => 8/478091 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5669 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274149.pdf [firstpage_image] =>[orig_patent_app_number] => 478091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772725 [patent_doc_number] => 05817471 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor' [patent_app_type] => 1 [patent_app_number] => 8/480553 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 10348 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817471.pdf [firstpage_image] =>[orig_patent_app_number] => 480553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4183927 [patent_doc_number] => 06153193 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Compositions for targeting biological agents' [patent_app_type] => 1 [patent_app_number] => 8/478979 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12469 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153193.pdf [firstpage_image] =>[orig_patent_app_number] => 478979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828497 [patent_doc_number] => 20020068327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'NON-NATURALLY OCCURRING TARGETED LIPOLYTIC COMPOUNDS AND RELATED COMPOSITIONS AND METHODS' [patent_app_type] => new [patent_app_number] => 08/483228 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9539 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068327.pdf [firstpage_image] =>[orig_patent_app_number] => 08483228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777391 [patent_doc_number] => 05817769 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Antibodies to mammalian adipogenic factors' [patent_app_type] => 1 [patent_app_number] => 8/476034 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 14668 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817769.pdf [firstpage_image] =>[orig_patent_app_number] => 476034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355639 [patent_doc_number] => 06291641 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Hepatitis E virus antigens and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/477292 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 23014 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291641.pdf [firstpage_image] =>[orig_patent_app_number] => 477292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1373899 [patent_doc_number] => 06558898 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use' [patent_app_type] => B1 [patent_app_number] => 08/488446 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 53 [patent_no_of_words] => 70924 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/558/06558898.pdf [firstpage_image] =>[orig_patent_app_number] => 08488446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4376755 [patent_doc_number] => 06303388 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Process for preparing novel ice-controlling molecules' [patent_app_type] => 1 [patent_app_number] => 8/485185 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 9077 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303388.pdf [firstpage_image] =>[orig_patent_app_number] => 485185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991446 [patent_doc_number] => 05919615 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them' [patent_app_type] => 1 [patent_app_number] => 8/470471 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 13946 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919615.pdf [firstpage_image] =>[orig_patent_app_number] => 470471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046786 [patent_doc_number] => 05932224 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus' [patent_app_type] => 1 [patent_app_number] => 8/469830 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 11785 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932224.pdf [firstpage_image] =>[orig_patent_app_number] => 469830 [rel_patent_id] =>[rel_patent_doc_number] =>)